Importance of Qualification, Computer System Validation and its Regulatory Compliance in Pharmaceutical Industry
In the pharmaceutical sector computer systems are integrated into the regular operations. The process or operation being controlled or monitored by the computer system, the procedural controls, and process related documentation, and the people. Computer systems performing regulated operations may control the quality of a product during its development, testing, manufacturing, and handling processes; manage information business operations; manage data used to prove the safety; efficacy and quality of the product and formulation. Systematic qualification and computer system validation helps to prevent software problems from production environment. A problem in a Pharmaceutical software application which affects the production environment can result in serious adverse consequence and also affect the product quality and business firm like lawsuits, financial penalties which ultimately results the company suffering from economic instabilities, staff downsizing and possibly eventual bankruptcy. The purpose of this industrial based research paper is to present and describe the steps as well as process involve in qualification and computer system validation of instrument/equipment used in pharmaceutical industry with current regulatory guidance
2. U.S. Food and Drug Administration, Guidance for Industry: 21 CFR Part 11; Electronic Records. Electronic Signatures Part 11 Scope and Application; 2003.
3. International Standards Organization, ISO Standard 14971 - Medical Devices - Application of Risk Management to Medical Devices, International Standards Organization, Geneva; 2000.
4. Guidance on equipment qualification of analytical instruments, Accreditation and Quality Assurance. 1996; 1(6):265-74.
5. Coombes P, Laboratory Systems Validation Testing and Practice, DHI Publishing, LTD, Raleigh, USA; 2002.
6. US Food & Drug Administration - Guidance for Industry Quality Systems Approach to Pharmaceutical Current Good Manufacturing Practice Regulations; Sept 2006.
7. GAMP Forum – GAMP Good Practice Guide, A Risk-Based Approach to Operation of GxP Computerized Systems; 2010.
8. US Food & Drug Administration - Guidance for Industry Process Validation: General Principles and Practices – Revision 1; Jan 2011.
9. US Food & Drug Administration - General Principles of Software Validation; Final Guidance for Industry and FDA Staff; Jan 2002.
10. PIC/S Good Practices for computerized systems in regulated “GxP” environment, Pharmaceutical Inspection Co-operation Scheme guidance; Sept 2007.
11. GAMP Forum – GAMP Guide, A Risk-Based Approach to complaint GxP Computerized Systems - Ver. 5.0.
12. GAMP Forum – GAMP Good Practice Guide, Global Information Systems Control and Compliance.
13. Society of Quality Assurance, Computer Validation Initiative Committee (CVIC), Risk Assessment /Validation Priority Setting.
14. GAMP Forum, Good Practice Guide - IT Infrastructure Control and Compliance, International Society for Pharmaceutical Engineering, Tampa, FL; 2005.
15. McDowall R. D.In Computer Systems Validation: Quality Assurance, Risk Management and Regulatory Compliance for Pharmaceutical and Healthcare Companies, Interpharm / CRC, Boca Raton, FL; 2004.
16. Agalloco, J, Carleton FJ. Validation of Pharmaceutical Process. 3rd Edition. USA, New York: Informa Healthcare; 2008.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM